Search Results

Displaying Results 1-8 of 8 "'ABIO'"

Aug 26, 2026, 06:00 ET The Crime Before the Crime

(https://drive.google.com/file/d/16ejjfC1w2kiIbuP2xM5M9_AbiO1gR69s/view?usp=sharing)

More news about: Alcatraz


Aug 25, 2026, 06:00 ET 58% of Americans Can't Name the Security Failure Behind Intruder Breaches at Harvard, UCLA and 30 Rockefeller Center

(https://drive.google.com/file/d/16ejjfC1w2kiIbuP2xM5M9_AbiO1gR69s/view?usp=sharing)

More news about: Alcatraz


Feb 09, 2026, 09:00 ET Architecting the Intelligent Lab of the Future: Abio Technologies Launches Abio Spark and Blaze at SLAS2026

the Abio ecosystem to act as the unified backbone for the lab," said Guochun Liao, President of Abio Technologies Inc. "Abio Spark provides the 'Seed' of high-integrity research, while Abio Blaze provides the 'Engine' to drive that discovery into high-throughput reality".The Abio EcosystemThe

More news about: Abio Technologies Inc.


Feb 09, 2026, 09:00 ET Architecting the Intelligent Lab of the Future: Abio Technologies Launches Abio Spark and Blaze at SLAS2026

2027.AvailabilityAbio Spark is available now for free public access at software.abio.ai. Abio Blaze is currently available for prospect demonstrations. Visit the Abio booth at SLAS2026 for live demonstrations of the intelligent lab in action.About Abio Technologies Inc.Abio Technologies

More news about: Abio Technologies Inc.


Dec 19, 2025, 19:09 ET Das in Singapur ansässige Startup-Unternehmen Galatek sammelt 30 Millionen US-Dollar in einer Serie-A-Finanzierungsrunde ein, um die KI-gestützte Automatisierung in den Bereichen Biowissenschaften und Halbleiterfertigung voranzutreiben

3D-Zell- und Organoidkultur, Arzneimittelentwicklung und synthetischer Biologie schneller voranzutreiben und Risiken zu minimieren. Das wird durch die Abio-Softwareplattform von Galatek noch besser, eine integrierte KI-gesteuerte Lösung, die ELN, LIMS, SDMS und fortschrittliche Automatisierung zusammenbringt,

More news about: Galatek


Dec 19, 2025, 08:06 ET Galatek, une startup basée à Singapour, lève 30 millions de dollars de série A pour accélérer l'automatisation basée sur l'IA dans les sciences de la vie et la fabrication de semi-conducteurs.

de cellules et d'organoïdes en 3D, le développement de médicaments et la biologie synthétique. Ceci est encore renforcé par la plateforme logicielle Abio de Galatek, une solution intégrée pilotée par l'IA qui unifie l'ordinateur portable de laboratoire (ELN), le système de gestion des informations de

More news about: Galatek


Sep 23, 2025, 07:59 ET MLAB Biosciences Expands Scientific Advisory Board with Appointments of Peter Kang and Kathryn Wagner, Deepening Scientific Expertise in Neuromuscular Medicine

development. About MLAB Biosciences MLAB is a biotechnology company incubated by ABio-X Holding ("ABio-X") with a focus on accelerating breakthroughs in protein therapeutic development for musculoskeletal diseases. ABio-X is a next-generation incubation platform creating life sciences companies at the

More news about: MLAB Biosciences


Sep 15, 2025, 09:00 ET MLAB Biosciences Appoints Dr. Edward M. Kaye as Chair of Scientific Advisory Board

experts. About MLAB Biosciences MLAB is a biotechnology company incubated by ABio-X Holding ("ABio-X") with a focus on accelerating breakthroughs in protein therapeutic development for musculoskeletal diseases. ABio-X is a next-generation incubation platform creating life sciences companies at the

More news about: MLAB Biosciences


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.